- This line was added.
- This line was removed.
- Formatting was changed.
This collection contains a small subset of ACRIN 6684 trial data intended for use in Quantitative Imaging Network (QIN) projects. Additional follow-up scans which were not part of the ACRIN trial are provided by Mark Muzi and Dr. James Fink from University of Washington. Each study contains DCE, DSC, DTI and BOLD imaging data along with the conventional imaging (T1, T2, FLAIR, MPRAGE). The MR data was collected on a Philips Achieva 3T MR. Acquisition sequences and the patient cohort are described further in the Detailed Description tab below. Funding sources for this data set include: P01-CA042045 (Mark Muzi), UW U01-CA148131 (Paul E. Kinahan) and GERRAF (James R. Fink), ACRIN U01 CA080098, ACRIN U01 CA079778.
About the NCI QIN
The mission of the QIN is to improve the role of quantitative imaging for clinical decision making in oncology by developing and validating data acquisition, analysis methods, and tools to tailor treatment for individual patients and predict or monitor the response to drug or radiation therapy. More information is available on the Quantitative Imaging Network Collections page. Interested investigators can apply to the QIN at: Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) PAR-11-150.